When doctors told the father of two his cancer was seen just three times a year in Oregon, he found a lifeline 2,000 miles ...

Interest in the intraperitoneal delivery of chemotherapy to patients with ovarian cancer with minimal residual disease following initial cytoreductive surgery has been rekindled with the recent ...

American Oncology Institute (AOI) at ASCOMS Jammu has achieved a significant breakthrough in complex cancer treatment by ...

Due to a lack of robust evidence, the benefits and risks of adding chemotherapy directly into the abdominal cavity (intraperitoneal chemotherapy, or IPC) for stomach cancer are unclear.

Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial This was a multicenter randomized phase ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

CHICAGO — Intraperitoneal (IP) chemotherapy is now an alternative to intravenous (IV) administration that "must be discussed" for women with cytoreduced ovarian cancer, several experts said here at ...

Prestigious European Society for Medical Oncology Conference “trials-in-progress” sessionPivotal OVATION 3 trial of its DNA-mediated ...

Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a promising treatment approach for patients with peritoneal carcinomatosis, particularly ...

Medically reviewed by Doru Paul, MD Key Takeaways Peritoneal cancer is a rare cancer that starts in the thin tissue lining the abdomen.Symptoms often appear late and can include abdominal pain, ...

FOX CHASE (WPVI) -- HIPEC is an often overlooked form of chemotherapy, with a long track record. It's improving survival rates in some abdominal cancers, however, some patients and doctors may not ...